IL10 and myeloid sarcoma: IL-10 can be regarded in the context of the immune response as a “double-edged sword.” It has been established that MS patients show diminished IL-10 secretion by B1 cells (and Breg cells), suggesting that a defect in the B1-cell compartment could be involved in the disease [256,257].